OPKO Health, Inc.

URI: https://gptkb.org/entity/OPKO_Health%2C_Inc.

GPTKB entity

Statements (79)

Predicate	Object
gptkbp:instanceOf	gptkb:Company
gptkbp:acquisition	gptkb:BioReference_Laboratories gptkb:Eagle_Pharmaceuticals gptkb:Prolor_Biotech gptkb:Renaissance_Pharma
gptkbp:CEO	gptkb:Phillip_Frost
gptkbp:clinicalTrials	Yes
gptkbp:employees	Approximately 1,000
gptkbp:focus	Diagnostics Therapeutics
gptkbp:founded	2007
gptkbp:founder	gptkb:Phillip_Frost
gptkbp:headCoach	gptkb:Dr._David_O._H._Lee
gptkbp:headquarters	gptkb:Miami,_Florida
https://www.w3.org/2000/01/rdf-schema#label	OPKO Health, Inc.
gptkbp:industry	Biotechnology
gptkbp:partnerships	gptkb:Pfizer gptkb:Teva_Pharmaceuticals
gptkbp:products	gptkb:OPKO_400 gptkb:OPKO_3300 gptkb:OPKO_4000 gptkb:OPKO_4500 gptkb:OPKO_500 gptkb:OPKO_3400 gptkb:OPKO_3200 gptkb:OPKO_4700 gptkb:OPKO_3900 gptkb:OPKO_4200 gptkb:OPKO_4100 gptkb:OPKO_1800 gptkb:OPKO_2900 gptkb:OPKO_1600 gptkb:OPKO_2100 gptkb:OPKO_2200 gptkb:Rayaldee gptkb:OPKO_4600 gptkb:OPKO_1400 gptkb:OPKO_1300 gptkb:OPKO_3000 gptkb:OPKO_3100 gptkb:OPKO_1900 gptkb:OPKO_3500 gptkb:OPKO_1700 gptkb:OPKO_3800 gptkb:OPKO_600 gptkb:OPKO_1100 gptkb:Vascepa gptkb:OPKO_200 gptkb:OPKO_3700 gptkb:OPKO_1200 gptkb:OPKO_2500 gptkb:OPKO_1500 gptkb:OPKO_5000 gptkb:OPKO_300 gptkb:OPKO_2800 gptkb:OPKO_4300 gptkb:OPKO_2300 gptkb:OPKO_1000 gptkb:OPKO_3600 gptkb:OPKO_900 gptkb:OPKO_2000 gptkb:OPKO_800 gptkb:OPKO_4400 gptkb:OPKO_2700 gptkb:OPKO_4800 gptkb:OPKO_2600 gptkb:OPKO_4900 gptkb:OPKO_2400 Pharmaceuticals Diagnostic tests OPKO 700
gptkbp:researchFocus	Cardiovascular diseases Chronic kidney disease Growth hormone deficiency
gptkbp:revenue	$100 million (2020)
gptkbp:stockSymbol	OPK
gptkbp:subsidiary	gptkb:OPKO_Lab
gptkbp:tradedOn	gptkb:NASDAQ
gptkbp:website	www.opko.com